Literature DB >> 9506557

In vivo PET imaging in rat of dopamine terminals reveals functional neural transplants.

A L Brownell1, E Livni, W Galpern, O Isacson.   

Abstract

Positron emission tomography (PET) and carbon-11-labeled 2B-carbomethoxy-3B-(4-fluorophenyl)tropane (11C-CFT or 11-WIN 35,428) were used as molecular markers for striatal presynaptic dopamine (DA) transporters in a unilateral Parkinson's disease rat neurotransplantation model. In the lesioned striatum, the binding ratio measured by the DA presynaptic marker was reduced to 15% to 35% of the intact side (or unoperated control). After grafting with non-DA cells (from dorsal mesencephalon), the DA binding ratio remained reduced to levels observed before transplantation and rats showed no behavioral recovery. In contrast, after DA neuronal transplantation, behavioral recovery occurred only after the 11C-CFT binding ratio had increased to 75% to 85% of the intact side. This study provides direct in vivo evidence for the dopaminergic molecular basis of functional recovery in the lesioned nigrostriatal system after neural transplantation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506557     DOI: 10.1002/ana.410430318

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

Review 1.  Aspects of PET imaging relevant to the assessment of striatal transplantation in Huntington's disease.

Authors:  L Besret; A L Kendall; S B Dunnett
Journal:  J Anat       Date:  2000-05       Impact factor: 2.610

2.  Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model.

Authors:  Lars M Bjorklund; Rosario Sánchez-Pernaute; Sangmi Chung; Therese Andersson; Iris Yin Ching Chen; Kevin St P McNaught; Anna-Liisa Brownell; Bruce G Jenkins; Claes Wahlestedt; Kwang-Soo Kim; Ole Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-08       Impact factor: 11.205

3.  Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.

Authors:  Penelope J Hallett; Michela Deleidi; Arnar Astradsson; Gaynor A Smith; Oliver Cooper; Teresia M Osborn; Maria Sundberg; Michele A Moore; Eduardo Perez-Torres; Anna-Liisa Brownell; James M Schumacher; Roger D Spealman; Ole Isacson
Journal:  Cell Stem Cell       Date:  2015-02-26       Impact factor: 24.633

4.  Implantation of olfactory ensheathing cells promotes neuroplasticity in murine models of stroke.

Authors:  Woei-Cherng Shyu; Demeral David Liu; Shinn-Zong Lin; Wen-Wen Li; Ching-Yuan Su; Ying-Chen Chang; Hsiao-Jung Wang; Hsing-Won Wang; Chang-Hai Tsai; Hung Li
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

5.  Future of cell and gene therapies for Parkinson's disease.

Authors:  Ole Isacson; Jeffrey H Kordower
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

6.  PET∕CT imaging evidence of FUS-mediated (18)F-FDG uptake changes in rat brain.

Authors:  Hyungmin Kim; Mi-Ae Park; Shuyan Wang; Alan Chiu; Krisztina Fischer; Seung-Schik Yoo
Journal:  Med Phys       Date:  2013-03       Impact factor: 4.071

7.  Functional modulation of G-protein coupled receptors during Parkinson disease-like neurodegeneration.

Authors:  Bruce G Jenkins; Aijun Zhu; Pekka Poutiainen; Ji-Kyung Choi; Kun-Eek Kil; Zhaoda Zhang; Darshini Kuruppu; Nurgul Aytan; Alpaslan Dedeoglu; Anna-Liisa Brownell
Journal:  Neuropharmacology       Date:  2015-11-12       Impact factor: 5.250

8.  Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.

Authors:  Bruce G Jenkins; Rosario Sanchez-Pernaute; Anna-Liisa Brownell; Yin-Ching Iris Chen; Ole Isacson
Journal:  J Neurosci       Date:  2004-10-27       Impact factor: 6.709

9.  Stem cell therapy for Parkinson's disease.

Authors:  Lars M Björklund
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

10.  Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke.

Authors:  Yung-Luen Yu; Ruey-Hwang Chou; Woei-Cherng Shyu; Shu-Ching Hsieh; Chen-Shiou Wu; Shu-Ya Chiang; Wei-Jung Chang; Jia-Ni Chen; Yen-Ju Tseng; Yu-Hsuan Lin; Wei Lee; Su-Peng Yeh; Jennifer L Hsu; Cheng-Chieh Yang; Shih-Chieh Hung; Mien-Chie Hung
Journal:  EMBO Mol Med       Date:  2013-03-25       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.